Cargando…

Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune res...

Descripción completa

Detalles Bibliográficos
Autores principales: Walle, Thomas, Kraske, Joscha A., Liao, Boyu, Lenoir, Bénédicte, Timke, Carmen, von Bohlen und Halbach, Emilia, Tran, Florian, Griebel, Paul, Albrecht, Dorothee, Ahmed, Azaz, Suarez-Carmona, Meggy, Jiménez-Sánchez, Alejandro, Beikert, Tizian, Tietz-Dahlfuß, Alexandra, Menevse, Ayse Nur, Schmidt, Gabriele, Brom, Manuela, Pahl, Jens H. W., Antonopoulos, Wiebke, Miller, Matthias, Perez, Ramon Lopez, Bestvater, Felix, Giese, Nathalia A., Beckhove, Philipp, Rosenstiel, Philip, Jäger, Dirk, Strobel, Oliver, Pe’er, Dana, Halama, Niels, Debus, Jürgen, Cerwenka, Adelheid, Huber, Peter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942354/
https://www.ncbi.nlm.nih.gov/pubmed/35319989
http://dx.doi.org/10.1126/sciadv.abh4050
_version_ 1784673290764156928
author Walle, Thomas
Kraske, Joscha A.
Liao, Boyu
Lenoir, Bénédicte
Timke, Carmen
von Bohlen und Halbach, Emilia
Tran, Florian
Griebel, Paul
Albrecht, Dorothee
Ahmed, Azaz
Suarez-Carmona, Meggy
Jiménez-Sánchez, Alejandro
Beikert, Tizian
Tietz-Dahlfuß, Alexandra
Menevse, Ayse Nur
Schmidt, Gabriele
Brom, Manuela
Pahl, Jens H. W.
Antonopoulos, Wiebke
Miller, Matthias
Perez, Ramon Lopez
Bestvater, Felix
Giese, Nathalia A.
Beckhove, Philipp
Rosenstiel, Philip
Jäger, Dirk
Strobel, Oliver
Pe’er, Dana
Halama, Niels
Debus, Jürgen
Cerwenka, Adelheid
Huber, Peter E.
author_facet Walle, Thomas
Kraske, Joscha A.
Liao, Boyu
Lenoir, Bénédicte
Timke, Carmen
von Bohlen und Halbach, Emilia
Tran, Florian
Griebel, Paul
Albrecht, Dorothee
Ahmed, Azaz
Suarez-Carmona, Meggy
Jiménez-Sánchez, Alejandro
Beikert, Tizian
Tietz-Dahlfuß, Alexandra
Menevse, Ayse Nur
Schmidt, Gabriele
Brom, Manuela
Pahl, Jens H. W.
Antonopoulos, Wiebke
Miller, Matthias
Perez, Ramon Lopez
Bestvater, Felix
Giese, Nathalia A.
Beckhove, Philipp
Rosenstiel, Philip
Jäger, Dirk
Strobel, Oliver
Pe’er, Dana
Halama, Niels
Debus, Jürgen
Cerwenka, Adelheid
Huber, Peter E.
author_sort Walle, Thomas
collection PubMed
description Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8–dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56(dim)-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56(dim) NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy.
format Online
Article
Text
id pubmed-8942354
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-89423542022-04-04 Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8 Walle, Thomas Kraske, Joscha A. Liao, Boyu Lenoir, Bénédicte Timke, Carmen von Bohlen und Halbach, Emilia Tran, Florian Griebel, Paul Albrecht, Dorothee Ahmed, Azaz Suarez-Carmona, Meggy Jiménez-Sánchez, Alejandro Beikert, Tizian Tietz-Dahlfuß, Alexandra Menevse, Ayse Nur Schmidt, Gabriele Brom, Manuela Pahl, Jens H. W. Antonopoulos, Wiebke Miller, Matthias Perez, Ramon Lopez Bestvater, Felix Giese, Nathalia A. Beckhove, Philipp Rosenstiel, Philip Jäger, Dirk Strobel, Oliver Pe’er, Dana Halama, Niels Debus, Jürgen Cerwenka, Adelheid Huber, Peter E. Sci Adv Biomedicine and Life Sciences Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8–dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56(dim)-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56(dim) NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy. American Association for the Advancement of Science 2022-03-23 /pmc/articles/PMC8942354/ /pubmed/35319989 http://dx.doi.org/10.1126/sciadv.abh4050 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Walle, Thomas
Kraske, Joscha A.
Liao, Boyu
Lenoir, Bénédicte
Timke, Carmen
von Bohlen und Halbach, Emilia
Tran, Florian
Griebel, Paul
Albrecht, Dorothee
Ahmed, Azaz
Suarez-Carmona, Meggy
Jiménez-Sánchez, Alejandro
Beikert, Tizian
Tietz-Dahlfuß, Alexandra
Menevse, Ayse Nur
Schmidt, Gabriele
Brom, Manuela
Pahl, Jens H. W.
Antonopoulos, Wiebke
Miller, Matthias
Perez, Ramon Lopez
Bestvater, Felix
Giese, Nathalia A.
Beckhove, Philipp
Rosenstiel, Philip
Jäger, Dirk
Strobel, Oliver
Pe’er, Dana
Halama, Niels
Debus, Jürgen
Cerwenka, Adelheid
Huber, Peter E.
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
title Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
title_full Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
title_fullStr Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
title_full_unstemmed Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
title_short Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
title_sort radiotherapy orchestrates natural killer cell dependent antitumor immune responses through cxcl8
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942354/
https://www.ncbi.nlm.nih.gov/pubmed/35319989
http://dx.doi.org/10.1126/sciadv.abh4050
work_keys_str_mv AT wallethomas radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT kraskejoschaa radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT liaoboyu radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT lenoirbenedicte radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT timkecarmen radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT vonbohlenundhalbachemilia radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT tranflorian radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT griebelpaul radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT albrechtdorothee radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT ahmedazaz radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT suarezcarmonameggy radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT jimenezsanchezalejandro radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT beikerttizian radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT tietzdahlfußalexandra radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT menevseaysenur radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT schmidtgabriele radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT brommanuela radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT pahljenshw radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT antonopouloswiebke radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT millermatthias radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT perezramonlopez radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT bestvaterfelix radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT giesenathaliaa radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT beckhovephilipp radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT rosenstielphilip radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT jagerdirk radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT strobeloliver radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT peerdana radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT halamaniels radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT debusjurgen radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT cerwenkaadelheid radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8
AT huberpetere radiotherapyorchestratesnaturalkillercelldependentantitumorimmuneresponsesthroughcxcl8